2nd Annual GPCR Congress

Venue: Le Montreux Palace

Location: Montreux, Switzerland

Event Date/Time: Jun 09, 2010 End Date/Time: Jun 10, 2010
Report as Spam


Oxford Global Conferences is proud to present the GPCR Congress 2010 which is to be held on the 9th & 10th June in Montreux, Switzerland. The congress is the single most focused event in Europe dedicated to key technological and scientific trends in GPCR’s in the pharmaceutical and biotech industry, as well as academic institutions. It will also be co-located with our 11th Annual Drug Discovery Leaders Summit.

This conference explores effective strategies, technologies and applications of GPCR in accelerating drug targeting, discovery and early development. Over two days, the 2 events will attract over 150 senior-level decision makers working in drug targeting, design, discovery and development from the UK, Europe and US. This prestigious event provides a forum for practitioners and researchers to learn more about key solutions being provided to their industry, network with their peers and address key industry concerns through a series of cutting edge conference presentations in a professional yet relaxed environment, during a 2 day conference programme.

Day 1

Closer studies into various aspects of GPCR’s including allosteric modulations from a chemistry and biology aspect, dimerisation and oligomerisation

Latest approaches to other important aspects of GPCR’s - including the role of signaling and trafficking, functional selectivity, polypharmacology and Drug Discovery Programmes

Day 2

Examining the implementation of GPCR screening methods, HTS, HCS as well as exploring the roles of cell and label free screening, assay technology as well as determining cost effective assay formats.

Focus upon the optimization of all areas of GPCR medicinal chemistry including structure, mechanism, SAR, protein and ligand structure based drug design and molecular and in silico modelling

Who will attend:
Delegates are pre-qualified dependent on budget, responsibility and seniority. Delegates are senior-level decision makers, from major pharmaceutical, biotech companies and research institutions based in Europe and typically include VPs, Directors, Managers and Heads of:
Drug Target Biomarkers Bioinformatics
Drug Design Screening Molecular Pharmacology
Molecular Profiling Medicinal Chemistry Lead Discovery
Imaging Protein Engineering Clinical Diagnostics
Structural Biology Optimisation & Validation SAR
Molecular Biology Fragment Based Assay Development Proteomic Chemistry
Label Free Technologies Oligomerisation Genomics
7tm Polypharmacology Allosterism